Clinical Impact of the Adaptation of Initial Tacrolimus Dosing to the CYP3A5 Genotype After Kidney Transplantation: Systematic Review and Meta-Analysis of Randomized Controlled Trials-Reference-Cited by-同舟云学术

Clinical Impact of the Adaptation of Initial Tacrolimus Dosing to the CYP3A5 Genotype After Kidney Transplantation: Systematic Review and Meta-Analysis of Randomized Controlled Trials

Published:2021-03-10 Issue:7 Volume:60 Page:877-885
ISSN:0312-5963
Container-title:Clinical Pharmacokinetics
language:en
Short-container-title:Clin Pharmacokinet

Author:

Yang Hui,Sun Yiqi,Yu Xiaojia,Hu Xiaopeng,Wang Wei,Zhang Xiaodong,Liu Lihong

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology

Link

https://link.springer.com/content/pdf/10.1007/s40262-020-00955-2.pdf

Reference31 articles.

1. Thölking G, Gerth HU, Schuette-Nuetgen K, et al. Influence of tacrolimus metabolism rate on renal function after solid organ transplantation. World J Transplant. 2017;7(1):26–33.

2. Muraki Y. Factors affecting the pharmacokinetics after living donor liver transplant. Yakugaku Zasshi. 2012;132(9):1011–7.

3. Gonzalez D, Rao GG, Bailey SC, et al. Precision dosing: public health need, proposed framework, and anticipated impact. Clin Transl Sci. 2017;10(6):443–54.

4. Ferraris JR, Argibay PF, Costa L, et al. Influence of CYP3A5 polymorphism on tacrolimus maintenance doses and serum levels after renal transplantation: age dependency and pharmacological interaction with steroids. Pediatr Transplant. 2011;15(5):525–32.

5. Birdwell KA, Decker B, Barbarino JM, et al. Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for CYP3A5 genotype and tacrolimus dosing. Clin Pharmacol Ther. 2015;98(1):19–24.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluating the evidence for genotype‐informed Bayesian dosing of tacrolimus in children undergoing solid organ transplantation: A systematic literature review;British Journal of Clinical Pharmacology;2024-08-15

2. Tools for a personalized tacrolimus dose adjustment in the follow-up of renal transplant recipients. Metabolizing phenotype according to CYP3A genetic polymorphisms versus concentration-dose ratio;Nefrología (English Edition);2024-03

3. Population pharmacokinetic models of tacrolimus in paediatric solid organ transplant recipients: A systematic review;British Journal of Clinical Pharmacology;2023-10-04

4. CYP3A5 Polymorphism in Renal Transplantation: A Key to Personalized Immunosuppression;Transplantation Proceedings;2023-06

5. Effect of Wuzhi preparations on tacrolimus in CYP3A5 expressers during the early period after transplantation: A real-life experience from heart transplant recipients;Transplant Immunology;2023-02